Wang, T.-W.; Chao, H.-S.; Chiu, H.-Y.; Lin, Y.-H.; Chen, H.-C.; Lu, C.-F.; Liao, C.-Y.; Lee, Y.; Shiao, T.-H.; Chen, Y.-M.;
et al. Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients. Cancers 2023, 15, 5125.
https://doi.org/10.3390/cancers15215125
AMA Style
Wang T-W, Chao H-S, Chiu H-Y, Lin Y-H, Chen H-C, Lu C-F, Liao C-Y, Lee Y, Shiao T-H, Chen Y-M,
et al. Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients. Cancers. 2023; 15(21):5125.
https://doi.org/10.3390/cancers15215125
Chicago/Turabian Style
Wang, Ting-Wei, Heng-Sheng Chao, Hwa-Yen Chiu, Yi-Hui Lin, Hung-Chun Chen, Chia-Feng Lu, Chien-Yi Liao, Yen Lee, Tsu-Hui Shiao, Yuh-Min Chen,
and et al. 2023. "Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients" Cancers 15, no. 21: 5125.
https://doi.org/10.3390/cancers15215125
APA Style
Wang, T.-W., Chao, H.-S., Chiu, H.-Y., Lin, Y.-H., Chen, H.-C., Lu, C.-F., Liao, C.-Y., Lee, Y., Shiao, T.-H., Chen, Y.-M., Huang, J.-W., & Wu, Y.-T.
(2023). Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients. Cancers, 15(21), 5125.
https://doi.org/10.3390/cancers15215125
